K, R., K, G., Y, B., YT, C., M, P., C, Y., . . . L, S. (2026). Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis". Dermatology and therapy. https://doi.org/10.1007/s13555-026-01796-w
Chicago Style (17th ed.) CitationK, Rand, Gebauer K, Binamer Y, Cho YT, Papadimitropoulos M, Yang C, Agell H, Akmaz B, and Seminario-Vidal L. "Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis"." Dermatology and Therapy 2026. https://doi.org/10.1007/s13555-026-01796-w.
MLA (9th ed.) CitationK, Rand, et al. "Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis"." Dermatology and Therapy, 2026, https://doi.org/10.1007/s13555-026-01796-w.